Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

119.26
Delayed Data
As of 4:14pm ET
 -1.00 / -0.83%
Today’s Change
109.12
Today|||52-Week Range
162.00
-2.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line252.9M656.9M144.4M399.0M
 
 
 
 
 
Depreciation27.3M46.9M160.2M386.0M
 
 
 
 
 
Total Other Cash Flow120.4M-67.3M390.2M333.0M
 
 
 
 
 
Funds From Operations493.4M482.6M1.1B1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-3.9M-157.4M415.2M136.0M
 
 
 
 
 
Net Cash Flow - Operating Activities497.3M640.1M675.2M1.1B
 
 
 
 
 
 
InvestingIncrease In Investments-1.0B-667.7M-534.7M-675.0M
 
 
 
 
 
Decrease In Investments60.9M619.4M1.2B722.0M
 
 
 
 
 
Capital Expenditures-29.3M-136.7M-286.3M-333.0M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-3.9B0.00
 
 
Other Investing - Uses-9.3M-507.0K---1.0M
 
 
 
 
Other Investing - Sources0.00--5.5M--
 
 
Net Cash Flow Investing-1.0B-222.9M-3.6B-287.0M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.000.003.7B0.00
 
 
Long Term Debt Reduction-36.0M-55.5M-301.3M-375.0M
 
 
 
 
 
Net Proceeds Stock Sale71.3M114.4M77.9M37.0M
 
 
 
 
 
Common Preferred Redeemed-66.1M-302.6M-327.7M-430.0M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing105.7M251.1M26.0M0.00
 
 
 
 
Other Uses - Financing3.2M261.0K144.4M68.0M
 
 
 
 
 
Net Cash Flow - Financing71.6M7.1M3.0B-836.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.5M-10.2M-9.0M-7.0M
 
 
 
 
 
 
Net Change In Cash-458.2M424.3M75.1M-37.0M